Quadrivalent meningococcal conjugate vaccines
- PMID: 19477560
- DOI: 10.1016/j.vaccine.2009.05.003
Quadrivalent meningococcal conjugate vaccines
Abstract
Neisseria meningitidis is an important cause of bacterial meningitis and septicaemia with most disease caused by meningococci bearing serogroups A, B, C, Y and W-135 polysaccharides. Monovalent serogroup C conjugate vaccines have become established in the immunisation programmes in many countries and the first quadrivalent meningococcal vaccine, containing the polysaccharides from 4 of the serogroups A, C, Y and W-135 meningococci conjugated to a protein carrier was licensed in the US in 2005. This vaccine and others in development offer the potential to broaden population protection against meningococcal disease.
Similar articles
-
Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.Expert Rev Vaccines. 2009 May;8(5):529-42. doi: 10.1586/erv.09.18. Expert Rev Vaccines. 2009. PMID: 19397410 Review.
-
A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.Pediatr Infect Dis J. 2012 Jan;31(1):e15-23. doi: 10.1097/INF.0b013e31823e1e34. Pediatr Infect Dis J. 2012. PMID: 22094636 Clinical Trial.
-
Expanding prevention of invasive meningococcal disease.Expert Rev Vaccines. 2009 Jun;8(6):717-27. doi: 10.1586/erv.09.37. Expert Rev Vaccines. 2009. PMID: 19485753 Review.
-
[Meningococcal vaccines: from polysaccharide to conjugate vaccines].Arch Pediatr. 2012 Sep;19 Suppl 2:S61-4. doi: 10.1016/S0929-693X(12)71275-7. Arch Pediatr. 2012. PMID: 22883368 French.
-
An Update on Meningococcal Vaccination.R I Med J (2013). 2020 Aug 3;103(6):41-43. R I Med J (2013). 2020. PMID: 32752565 Review.
Cited by
-
Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers.Hum Vaccin Immunother. 2012 Dec 1;8(12):1892-903. doi: 10.4161/hv.22166. Epub 2012 Oct 2. Hum Vaccin Immunother. 2012. PMID: 23032159 Free PMC article. Clinical Trial.
-
Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.Infect Immun. 2015 Mar;83(3):996-1007. doi: 10.1128/IAI.03079-14. Epub 2014 Dec 29. Infect Immun. 2015. PMID: 25547792 Free PMC article.
-
Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding Protein.mBio. 2015 Jun 23;6(3):e00842. doi: 10.1128/mBio.00842-15. mBio. 2015. PMID: 26106082 Free PMC article.
-
Chicken Anti-Campylobacter Vaccine - Comparison of Various Carriers and Routes of Immunization.Front Microbiol. 2016 May 19;7:740. doi: 10.3389/fmicb.2016.00740. eCollection 2016. Front Microbiol. 2016. PMID: 27242755 Free PMC article.
-
The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysis.PLoS One. 2013 Sep 30;8(9):e76932. doi: 10.1371/journal.pone.0076932. eCollection 2013. PLoS One. 2013. PMID: 24098814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical